4.6 Article

Reactions to learning a not elevated amyloid PET result in a preclinical Alzheimer's disease trial

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Neurosciences

Subthreshold Amyloid Predicts Tau Deposition in Aging

Stephanie L. Leal et al.

JOURNAL OF NEUROSCIENCE (2018)

Article Clinical Neurology

Memory decline accompanies subthreshold amyloid accumulation

Susan M. Landau et al.

NEUROLOGY (2018)

Editorial Material Clinical Neurology

Study partners: essential collaborators in discovering treatments for Alzheimer's disease

Emily A. Largent et al.

ALZHEIMERS RESEARCH & THERAPY (2018)

Article Medicine, General & Internal

Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons

Michael C. Donohue et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)

Review Clinical Neurology

Study partners should be required in preclinical Alzheimer's disease trials

Joshua D. Grill et al.

ALZHEIMERS RESEARCH & THERAPY (2017)

Article Clinical Neurology

Safety of disclosing amyloid status in cognitively normal older adults

Jeffrey M. Burns et al.

ALZHEIMERS & DEMENTIA (2017)

Article Clinical Neurology

Patient and caregiver reactions to clinical amyloid imaging

Joshua D. Grill et al.

ALZHEIMERS & DEMENTIA (2017)

Review Biochemistry & Molecular Biology

Use of amyloid PET across the spectrum of Alzheimer's disease: clinical utility and associated ethical issues

Antoine Leuzy et al.

AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2014)

Review Clinical Neurology

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

Bruno Dubois et al.

LANCET NEUROLOGY (2014)

Editorial Material Cell Biology

The A4 Study: Stopping AD Before Symptoms Begin?

Reisa A. Sperling et al.

SCIENCE TRANSLATIONAL MEDICINE (2014)

Article Clinical Neurology

Disclosure of amyloid imaging results to research participants: Has the time come?

Jennifer H. Lingler et al.

ALZHEIMERS & DEMENTIA (2013)

Article Clinical Neurology

Should we disclose amyloid imaging results to cognitively normal individuals?

Joshua D. Grill et al.

NEURODEGENERATIVE DISEASE MANAGEMENT (2013)

Article Public, Environmental & Occupational Health

Making sense of nonsense: experiences of mild cognitive impairment

Renee L. Beard et al.

SOCIOLOGY OF HEALTH & ILLNESS (2013)

Article Clinical Neurology

Amyloid imaging, risk disclosure and Alzheimer's disease: ethical and practical issues

J. Scott Roberts et al.

NEURODEGENERATIVE DISEASE MANAGEMENT (2013)

Editorial Material Clinical Neurology

Predicting positivity for a new era of Alzheimer disease prevention trials

Jeffrey M. Burns et al.

NEUROLOGY (2012)

Review Clinical Neurology

The projected effect of risk factor reduction on Alzheimer's disease prevalence

Deborah E. Barnes et al.

LANCET NEUROLOGY (2011)